These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18635828)

  • 21. Myocardial CXCR4 expression is required for mesenchymal stem cell mediated repair following acute myocardial infarction.
    Dong F; Harvey J; Finan A; Weber K; Agarwal U; Penn MS
    Circulation; 2012 Jul; 126(3):314-24. PubMed ID: 22685115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catalpol Promotes the Survival and VEGF Secretion of Bone Marrow-Derived Stem Cells and Their Role in Myocardial Repair After Myocardial Infarction in Rats.
    Ju X; Xue D; Wang T; Ge B; Zhang Y; Li Z
    Cardiovasc Toxicol; 2018 Oct; 18(5):471-481. PubMed ID: 29752623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual Stem Cell Therapy Improves the Myocardial Recovery Post-Infarction through Reciprocal Modulation of Cell Functions.
    Popescu S; Preda MB; Marinescu CI; Simionescu M; Burlacu A
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel Mesenchymal Stem Cell Strategy in Alleviating Toll-Like Receptor-4, p53 and Nrf2 Signaling in Isoproterenol-Induced Myocardial Infarction in Rat Model.
    Kadry MO; Abdel-Megeed RM
    Cardiovasc Toxicol; 2018 Jun; 18(3):232-241. PubMed ID: 29110132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-10 Deficiency Alters Endothelial Progenitor Cell-Derived Exosome Reparative Effect on Myocardial Repair via Integrin-Linked Kinase Enrichment.
    Yue Y; Wang C; Benedict C; Huang G; Truongcao M; Roy R; Cimini M; Garikipati VNS; Cheng Z; Koch WJ; Kishore R
    Circ Res; 2020 Jan; 126(3):315-329. PubMed ID: 31815595
    [No Abstract]   [Full Text] [Related]  

  • 26. Self-assembling peptide modified with QHREDGS as a novel delivery system for mesenchymal stem cell transplantation after myocardial infarction.
    Cai H; Wu FY; Wang QL; Xu P; Mou FF; Shao SJ; Luo ZR; Zhu J; Xuan SS; Lu R; Guo HD
    FASEB J; 2019 Jul; 33(7):8306-8320. PubMed ID: 30970221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracoronary mesenchymal stem cells promote postischemic myocardial functional recovery, decrease inflammation, and reduce apoptosis via a signal transducer and activator of transcription 3 mechanism.
    Poynter JA; Herrmann JL; Manukyan MC; Wang Y; Abarbanell AM; Weil BR; Brewster BD; Meldrum DR
    J Am Coll Surg; 2011 Aug; 213(2):253-60. PubMed ID: 21546276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transplantation of mesenchymal stem cells overexpressing IL10 attenuates cardiac impairments in rats with myocardial infarction.
    Meng X; Li J; Yu M; Yang J; Zheng M; Zhang J; Sun C; Liang H; Liu L
    J Cell Physiol; 2018 Jan; 233(1):587-595. PubMed ID: 28322445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follistatin-like 1 protects mesenchymal stem cells from hypoxic damage and enhances their therapeutic efficacy in a mouse myocardial infarction model.
    Shen H; Cui G; Li Y; Ye W; Sun Y; Zhang Z; Li J; Xu G; Zeng X; Zhang Y; Zhang W; Huang Z; Chen W; Shen Z
    Stem Cell Res Ther; 2019 Jan; 10(1):17. PubMed ID: 30635025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transplantation with survivin-engineered mesenchymal stem cells results in better prognosis in a rat model of myocardial infarction.
    Fan L; Lin C; Zhuo S; Chen L; Liu N; Luo Y; Fang J; Huang Z; Lin Y; Chen J
    Eur J Heart Fail; 2009 Nov; 11(11):1023-30. PubMed ID: 19875403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway.
    Lin M; Liu X; Zheng H; Huang X; Wu Y; Huang A; Zhu H; Hu Y; Mai W; Huang Y
    Stem Cell Res Ther; 2020 Jan; 11(1):22. PubMed ID: 31918758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of Csx/Nkx2.5 and GATA-4 enhances the efficacy of mesenchymal stem cell transplantation after myocardial infarction.
    Gao XR; Tan YZ; Wang HJ
    Circ J; 2011; 75(11):2683-91. PubMed ID: 21828931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone marrow derived mesenchymal cell mobilization by granulocyte-colony stimulating factor after acute myocardial infarction: results from the Stem Cells in Myocardial Infarction (STEMMI) trial.
    Ripa RS; Haack-Sørensen M; Wang Y; Jørgensen E; Mortensen S; Bindslev L; Friis T; Kastrup J
    Circulation; 2007 Sep; 116(11 Suppl):I24-30. PubMed ID: 17846310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prompt bone marrow-derived mesenchymal stem cell therapy enables early porcine heart function recovery from acute myocardial infarction.
    Fan CQ; Leu S; Sheu JJ; Zhen YY; Tsai TH; Chen YL; Chung SY; Chai HT; Sun CK; Yang JL; Chang HW; Ko SF; Yip HK
    Int Heart J; 2014; 55(4):362-71. PubMed ID: 24965596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenosine Production by Biomaterial-Supported Mesenchymal Stromal Cells Reduces the Innate Inflammatory Response in Myocardial Ischemia/Reperfusion Injury.
    Shin EY; Wang L; Zemskova M; Deppen J; Xu K; Strobel F; García AJ; Tirouvanziam R; Levit RD
    J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29331956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous infusion of mesenchymal stem cells is associated with improved myocardial function during endotoxemia.
    Weil BR; Herrmann JL; Abarbanell AM; Manukyan MC; Poynter JA; Meldrum DR
    Shock; 2011 Sep; 36(3):235-41. PubMed ID: 21654558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of interleukin-7 in fusion of rat bone marrow mesenchymal stem cells with cardiomyocytes in vitro and improvement of cardiac function in vivo.
    Haneef K; Ali A; Khan I; Naeem N; Jamall S; Salim A
    Cardiovasc Ther; 2018 Dec; 36(6):e12479. PubMed ID: 30451388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. mi R -15a/15b Cluster Modulates Survival of Mesenchymal Stem Cells to Improve Its Therapeutic Efficacy of Myocardial Infarction.
    Tu Y; Qiu Y; Liu L; Huang T; Tang H; Liu Y; Guo W; Jiang H; Fan Y; Yu B
    J Am Heart Assoc; 2019 Jan; 8(1):e010157. PubMed ID: 30616426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TLR9 is essential for HMGB1-mediated post-myocardial infarction tissue repair through affecting apoptosis, cardiac healing, and angiogenesis.
    Liu FY; Fan D; Yang Z; Tang N; Guo Z; Ma SQ; Ma ZG; Wu HM; Deng W; Tang QZ
    Cell Death Dis; 2019 Jun; 10(7):480. PubMed ID: 31209243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesenchymal stem cell administration at coronary artery reperfusion in the rat by two delivery routes: a quantitative assessment.
    Hale SL; Dai W; Dow JS; Kloner RA
    Life Sci; 2008 Sep; 83(13-14):511-5. PubMed ID: 18755200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.